User:Ceyockey/Cresset BioMolecular Discovery

Cresset BioMolecular Discovery is a small English software and services company founded in 2001 that focuses on in silico drug discovery.

History
Andy Vinter founded Cresset in 2001 with money from the Wellcome Trust, specifically from the Catalyst BioMedica Ltd subsidiary of the Trust, which has since been integrated into the general technology transfer funding activities of the Trust.

Business model
Cresset revenues derive from two activities, software sales and collaborative research services. The flagship product was FieldScreen, launched in December 2004, which was followed by FieldTemplater in November 2005. In each case, research services provided proof-of-principle and field-testing of computational tools leading to productization and establishment of a secondary sales-based revenue stream. Based on news reports, Cresset has two major research partnerships, one with Pharmagene announced in March 2005 and a second with Bayer announced in January 2006.